{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:18:44Z","timestamp":1791778724817,"version":"4.3.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/mnm.0b013e32835bdfc9","type":"journal-article","created":{"date-parts":[[2012,12,31]],"date-time":"2012-12-31T12:32:06Z","timestamp":1356957126000},"page":"249-253","source":"Crossref","is-referenced-by-count":7,"title":["Reduction in the recurrence of meningiomas by combining somatostatin receptor scintigraphy of 99mTc-HYNIC-octreotide SPECT\/CT and radio guidance with a hand-held \u03b3-probe during surgery"],"prefix":"10.1097","volume":"34","author":[{"given":"Shengjun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fucheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20210212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0090-3019(86)90233-8","article-title":"Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy and outcome.","volume":"25","author":"Jaaskelainen","year":"1986","journal-title":"Surg Neurol"},{"key":"R3-8-20210212","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/B:NEON.0000013498.19981.55","article-title":"Expression of somatostatin receptor mRNA in human meningiomas and their implication in in-vitro antiproliferative activity.","volume":"66","author":"Arena","year":"2004","journal-title":"J Neurooncol"},{"key":"R4-8-20210212","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11060-004-2749-0","article-title":"Molecular pathogenesis of meningiomas.","volume":"70","author":"Perry","year":"2004","journal-title":"J Neurooncol"},{"key":"R5-8-20210212","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<620::AID-IJC2>3.0.CO;2-S","article-title":"Expression of somatostain receptor subtypes in human brain tumors.","volume":"76","author":"Dutour","year":"1998","journal-title":"Int J Cancer"},{"key":"R6-8-20210212","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5414\/NPP27334","article-title":"Expression of c-myc, neurofibromatosis type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes.","volume":"27","author":"Durdand","year":"2008","journal-title":"Clin Neuropathol"},{"key":"R7-8-20210212","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/B:NEON.0000013498.19981.55","article-title":"Expression of somatostatin receptor mRNA in human meningiomas and their implication in in-vitro antiproliferative activity.","volume":"66","author":"Arena","year":"2004","journal-title":"J Neurooncol"},{"key":"R8-8-20210212","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mce.2008.02.002","article-title":"Antitumor effects of somatostatin.","volume":"286","author":"Pyronnet","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"R9-8-20210212","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1600-0404.1987.tb05474.x","article-title":"Somatostatin suppression of meningioma cell proliferation in vitro.","volume":"75","author":"Kunert-Radek","year":"1987","journal-title":"Acta Neurol Scand"},{"key":"R10-8-20210212","first-page":"237","article-title":"Clinical use of octreotide in unresectable meningiomas. A report of three cases.","volume":"37","author":"Garcia-Luna","year":"1993","journal-title":"J Neurosurg Sci"},{"key":"R11-8-20210212","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1212\/01.wnl.0000271382.62776.b7","article-title":"Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.","volume":"69","author":"Chamberlain","year":"2007","journal-title":"Neurology"},{"key":"R12-8-20210212","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s002590050269","article-title":"Somatostatin receptor imaging in intracranial tumours.","volume":"25","author":"Schmidt","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"R13-8-20210212","first-page":"1767","article-title":"Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck.","volume":"44","author":"Duet","year":"2003","journal-title":"J Nucl Med"},{"key":"R14-8-20210212","first-page":"763","article-title":"Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.","volume":"46","author":"Henze","year":"2005","journal-title":"J Nucl Med"},{"key":"R15-8-20210212","first-page":"403","article-title":"Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability.","volume":"36","author":"Haldemann","year":"1995","journal-title":"J Nucl Med"},{"key":"R16-8-20210212","first-page":"1114","article-title":"99mTc-HYNIC-Tyr3-octreotide for imaging somatostatin-receptor-positive tumor: preclinical evaluation and comparison with 111In-octreotide.","volume":"41","author":"Decristoforo","year":"2000","journal-title":"J Nucl Med"},{"key":"R17-8-20210212","first-page":"853","article-title":"New somatostatin analogue99mTc-HYNIC-TOC in the scintigraphic diagnosis of medullary thyroid carcinoma.","volume":"116","author":"Czepczynski","year":"2006","journal-title":"Pol Arch Med Wewn"},{"key":"R18-8-20210212","first-page":"332","article-title":"99mTc-Octreotide in patients with neuroendocrine tumors from the GI tract.","volume":"40","author":"Gomez","year":"2010","journal-title":"Acta Gastroenterol Latinoam"},{"key":"R19-8-20210212","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1227\/01.NEU.0000330399.55586.63","article-title":"Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.","volume":"64","author":"Aghi","year":"2009","journal-title":"Neurosurgery"},{"key":"R20-8-20210212","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10014-009-0251-2","article-title":"Recurrence and regrowth of benign meningiomas.","volume":"26","author":"Nakasu","year":"2009","journal-title":"Brain Tumor Pathol"},{"key":"R21-8-20210212","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/jnnp.2007.121582","article-title":"Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.","volume":"79","author":"Yang","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R22-8-20210212","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00006123-199803000-00007","article-title":"Most intracranial meningiomas are not cleavable tumors: anatomicsurgical evidence and angiographic predictability.","volume":"42","author":"Sindou","year":"1998","journal-title":"Neurosurgery"},{"key":"R23-8-20210212","first-page":"1865","article-title":"Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A.","volume":"6","author":"Schulz","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R24-8-20210212","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s002590100541","article-title":"Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands.","volume":"28","author":"Reubi","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"R25-8-20210212","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/A:1014972520302","article-title":"The positive somatostatin receptor scintigraphy in primary breast cancer correlates with expression of ss2A and sst5.","volume":"72","author":"Schulz","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"R26-8-20210212","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/snuc.2002.31022","article-title":"Somatostatin receptor imaging.","volume":"32","author":"Kwekkeboom","year":"2002","journal-title":"Semin Nucl Med"},{"key":"R27-8-20210212","first-page":"403","article-title":"Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability.","volume":"36","author":"Haldemann","year":"1995","journal-title":"J Nucl Med"},{"key":"R28-8-20210212","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11060-006-9210-5","article-title":"The role of 111indium-octreotide brain scintigraphy in the diagnosis of cranial, dural-based meningiomas.","volume":"81","author":"Nathoo","year":"2007","journal-title":"J Neurooncol"},{"key":"R29-8-20210212","first-page":"1246","article-title":"Clinical value of 24-h delayed imaging in somatostatin receptor scintigraphy for meningioma.","volume":"40","author":"Klutmann","year":"1999","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0b013e32835bdfc9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:42:47Z","timestamp":1620963767000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-201303000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e32835bdfc9","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}